MERCK KGAA
- Country
- 🇩🇪Germany
- Ownership
- Public
- Established
- 1668-01-01
- Employees
- 62.9K
- Market Cap
- $84.2B
- Website
- http://www.merckgroup.com/de
A Retrospective Review of Liver Resection Rate in Metastatic Colorectal Cancer Patients Following Downsizing Treatment With Chemotherapy Plus Cetuximab in Normal UK National Health Service Clinical Practice
- Conditions
- First Posted Date
- 2011-10-27
- Last Posted Date
- 2014-02-04
- Lead Sponsor
- Merck KGaA, Darmstadt, Germany
- Target Recruit Count
- 60
- Registration Number
- NCT01460745
- Locations
- 🇬🇧
Merck Serono Research Site, Southampton, United Kingdom
Cetuximab in Refractory Colorectal Cancer With K-RAS Mutated and Favorable FcγRIIa (CD32) Genotype
- First Posted Date
- 2011-10-12
- Last Posted Date
- 2016-11-28
- Lead Sponsor
- Merck KGaA, Darmstadt, Germany
- Target Recruit Count
- 73
- Registration Number
- NCT01450319
- Locations
- 🇪🇸
Research Site, Valencia, Spain
To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Italy
- Conditions
- First Posted Date
- 2011-09-22
- Last Posted Date
- 2017-12-26
- Lead Sponsor
- Merck KGaA, Darmstadt, Germany
- Target Recruit Count
- 220
- Registration Number
- NCT01439061
- Locations
- 🇮🇹
For Locations in Italy, Please Contact The Merck KGaA Communication Center, Italy
Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ Electromechanical Device for Growth Hormone Treatment
- Conditions
- First Posted Date
- 2011-09-22
- Last Posted Date
- 2017-12-26
- Lead Sponsor
- Merck KGaA, Darmstadt, Germany
- Target Recruit Count
- 75
- Registration Number
- NCT01438528
- Locations
- 🇨🇳
For Recruiting Locations in China, Please Contact The Merck KGaA Communication Center, China
Common Safety Follow-up Trial of Tecemotide (L-BLP25)
- Conditions
- Interventions
- First Posted Date
- 2011-08-26
- Last Posted Date
- 2016-10-06
- Lead Sponsor
- Merck KGaA, Darmstadt, Germany
- Target Recruit Count
- 27
- Registration Number
- NCT01423760
- Locations
- 🇩🇪
Merck KGaA Communication Center, Darmstadt, Germany
First Year Growth Response Associated Genetic Markers Validation Phase IV Open-label Study in Growth Hormone Deficient and Turner Syndrome Pre-pubertal Children: the PREDICT Pharmacogenetics Validation Study
- Conditions
- Interventions
- First Posted Date
- 2011-08-18
- Last Posted Date
- 2014-01-16
- Lead Sponsor
- Merck KGaA, Darmstadt, Germany
- Target Recruit Count
- 458
- Registration Number
- NCT01419249
- Locations
- 🇨🇿
University Hospital Praha Motol, Praha, Czech Republic
🇨🇦University of Calgary - Alberta Children's Hospital, Calgary, Canada
🇦🇷Hospital de Niños Ricardo Gutiérrez, Buenos Aires, Argentina
A Korean Post-Marketing Surveillance Study On Pergoveris® (Follitropin Alfa + Lutropin Alfa)
- Conditions
- First Posted Date
- 2011-08-15
- Last Posted Date
- 2019-07-19
- Lead Sponsor
- Merck KGaA, Darmstadt, Germany
- Target Recruit Count
- 600
- Registration Number
- NCT01416987
- Locations
- 🇰🇷
Research site, Seoul, Korea, Republic of
To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Hungary
- Conditions
- First Posted Date
- 2011-07-27
- Last Posted Date
- 2017-12-26
- Lead Sponsor
- Merck KGaA, Darmstadt, Germany
- Target Recruit Count
- 83
- Registration Number
- NCT01402999
- Locations
- 🇭🇺
For Recruiting Locations in Hungary, Please Contact The Merck KGaA Communication Center, Hungary
Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Czech Republic
- Conditions
- First Posted Date
- 2011-07-25
- Last Posted Date
- 2017-12-26
- Lead Sponsor
- Merck KGaA, Darmstadt, Germany
- Target Recruit Count
- 206
- Registration Number
- NCT01400997
- Locations
- 🇨🇿
For Recruiting Locations in Czech Republic, Please Contact The Merck KGaA Communication Center, Czechia
To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Slovakia
- Conditions
- First Posted Date
- 2011-07-25
- Last Posted Date
- 2017-12-26
- Lead Sponsor
- Merck KGaA, Darmstadt, Germany
- Target Recruit Count
- 92
- Registration Number
- NCT01400984
- Locations
- 🇸🇰
For Recruiting Locations in Slovakia, Please Contact The Merck KGaA Communication Center, Slovakia